Dermatitis bullosa como efecto secundario a pembrolizumab

• المؤلفون الرئيسيون: Alícia da Silva Oliveira (مؤلف), Emílio Macias Bravo (مؤلف)
• التنسيق: كتاب
• منشور في: Sociedade Galega de Medicina Interna, 2022-01-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Adverse immunotherapy reactions are common and can affect virtually any organ system, with dermatological reactions, being some of the most commonly encountered. Bullous dermatitis can occur with anti-programmed cell death-1 treatment, although it is not amongst the common skin effects, it is a clin...